ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

277 hedge funds and large institutions have $7.86B invested in Alnylam Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 111 increasing their positions, 79 reducing their positions, and 24 closing their positions.

Holders
277
Holders Change
+40
Holders Change %
+16.88%
% of All Funds
7.47%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.3%
New
65
Increased
111
Reduced
79
Closed
24
Calls
$95.3M
Puts
$59.8M
Net Calls
+$35.5M
Net Calls Change
+$14.3M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$205M
2
State Street
2
State Street
Massachusetts
$176M
3
First Trust Advisors
3
First Trust Advisors
Illinois
$186M
4
TCIM
4
TIAA CREF Investment Management
New York
$49.5M
5
Canada Pension Plan Investment Board
5
Canada Pension Plan Investment Board
Ontario, Canada
$27.6M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.15B
2
CWAM
2
Columbia Wanger Asset Management
Illinois
$0
3
AWG
3
Alpha Wave Global
New York
$64.5M
4
GGHC
4
Gilder Gagnon Howe & Co
New York
$181M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$35.1M
Name Market Value Shares Shares
Change 		Shares
Change %
QT
301
Quantbot Technologies
New York
– – -15 Closed
TH
302
Timber Hill
Connecticut
– – – –
SM
303
Sabby Management
Florida
– – – –
HT
304
HAP Trading
New York
– – – –
9 10 11 12
13